Local Excision for Organ Preservation in Early REctal Cancer With No Adjuvant Treatment

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFundación de Investigación Biomédica - Hospital Universitario de La Princesa

About this trial

Rectal cancer is one of the most frequent malignant tumors nowadays. There are several possible treatment options including chemotherapy, radiotherapy and surgery. Surgery for early stage rectal cancer can be either a radical surgery (RS) or a local excision (LE).

A radical surgery removes the rectum including the tumor and the lymph nodes through which it spreads, improving survival but with a possible impact in the patients quality of life (QoL). A local excision only removes the tumor and a safety margin of healthy rectum. This has the potential to avoid the possible complications and QoL decrease. However there are some complications after a LE and also poor prognostic factors inherent to the tumor biology that can lead the surgical team to perform a RS after LE with worse outcomes. These are impossible to know before the procedure.

The goal of this registry is to determine the frequency of these poor prognostic biological factors and complications in patients undergoing LE for early rectal cancer.

The main question it aims to answer are:

• How frequently does LE allow for rectum preservation?

Participants will undergo LE for early rectal cancer when it is considered the best treatment by their surgeons according to their expertise and protocols. Patients will follow the standard treatment that would be given to them, and the biological prognostic factors and the appearance of complications will be recorded.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients age 18 years or older.

Histologic proof of infiltrating rectal adenocarcinoma. or

Preoperative biopsy compatible with rectal adenoma or intramucous adenocarcinoma with endoscopic or radiological suspicion of infiltrating adenocarcinoma.

Endoscopic criteria: Kudo´s crypt pattern of V or higher, despite non confirmatory preoperative histology. endoscópicos: patrón de criptas V o superior según la clasificación de Kudo, que define lesiones infiltrantes, a pesar de que la histología preoperatoria no sea confirmatoria .

Disqualifiers

Patients younger than 18 years old.

Rectal neoplasms different from adenocarcinoma.

Neoplasms in which the inferior edge is farther than 2cm proximal to the anorectal verge in the preoperative MR.

Any other clinical stage other than cT1N0M0 (any T>1, N+, or M+).

Trial population

Adults diagnosed with early stage rectal cancer, meaning clinical TNM staging cT1N0M0, programmed to receive Local Excision as an exclusive therapy according to each center´s standard practice.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Transanal local excision

    Procedure/Surgery

    Transanal full thickness local excision

Treatment groups

145 Participants
are divided into 1 treatment group
Group A: Local excision1 intervention

Trial outcomes

Primary outcomes

1

Success rate

Rate of patients with no need of Total Mesorectal Excision after follow-up

Time frame
36 months

Secondary outcomes

1

Morbidity rate

Postoperative complication rate, description, and severity according to Clavien Dindo classification

Time frame
2 months
2

Radicality of resection

Describe the rate of margin tumor infiltration

Time frame
1 month
3

Histological poor outcome predictor rate

Describe the rate of lymphatic, vascular and perineural invasion, histological grade, mean submucosal invasion depth

Time frame
1 month
4

Radical rescue surgery specimen quality

Describe the quality of Total Mesorectal Excision specimen in terms of mesorectal fascia integrity

Time frame
1 month

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

Lead sponsor

Hospital Alemão Oswaldo Cruz

Collaborator

Hospital Universitario La Fe

Collaborator

Complejo Hospitalario Universitario de Vigo

Collaborator